Per the deal, Volpara will provide its VolparaEnterprise software for use in the breast screening program. The deal follows a successful pilot trial with the software on the Gold Coast in Australia, Volpara said in a statement.

The rollout of VolparaEnterprise to BreastScreen Queensland has already begun, and Volpara expects it to go live in early 2021, the firm said in a statement. Financial terms of the deal were not disclosed.